J. Forst et al., Value of myofibrillar protein catabolic rate in Duchenne muscular dystrophy - A study after lower limb surgery, ARCH ORTHOP, 120(1-2), 2000, pp. 38-41
Previous studies have shown a decreased progression of the course in Duchen
ne muscular dystrophy (DMD) patients treated by lower limb surgery in early
childhood. The use of 3-methylhistidine (3-MH) excretion and 3-MH/creatini
ne excretion ratio as an appropriate indicator for the myofibrillar protein
catabolic rate (MPCR) in muscle disorders is discussed controversially. To
explore this issue we studied the renal excretion of (3-MH) over a period
up to 24 months (on average 20.8 +/- 1.4) after operation in 15 consecutive
DMD patients with an average age at operation of 8.75 (+/- 2.43 years) to
evaluate the myofibrillar protein catabolic rate. No significant change of
the MPCR could be found in our population over the follow-up period. Howeve
r, the formula for the calculation of the MPCR contains quantities which ar
e not precisely known in DMD or assumed to be constant over the progressive
course of DMD. Summarizing MPCR cannot be recommended for the assessment o
f therapeutic efficacy in DMD.